CEO: Jeffrey M Leiden

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.


Key numbers

Market Capitalization:58902779000
Shares Outstanding: 257150000
Float: 256609728
Next Earning Date:2020-01-30
TTm EPS: 8.3979
TTm Dividend Rate:
200 days moving average:188.23
50 days moving average: 221.56
One day percent Change: -2.07



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,